Testing in vitro maturation of eggs in women with fertility concerns
Tests in vitro maturation of human eggs in women with PCOS or infertility.
Key facts
- Who runs it
- Colorado Center for Reproductive Medicine
- Where
- Lone Tree, United StatesSee the site
- Trial code
- Registry title
- In Vitro Maturation of Human Eggs
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 3 Feb 2023
- Expected to end
- 30 Aug 2030
- Type of study
- Interventional
- Treatments tested
- IVM
- Record updated
- 9 October 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with fertility problems who have polycystic ovaries (PCOS) or a good egg supply, to test egg maturation in the lab (IVM).
- Age
- Up to 38 years.
- Sex
- Women only.
- Disease stage
- Infertility with PCOS or polycystic ovaries, or with good ovarian reserve. Antral follicle count greater than 24, AMH greater than 3.5 ng/ml.
- Earlier treatment
- No more than 2 failed IVF cycles.
- Biomarker or test result
- AMH greater than 3.5 ng/ml; antral follicle count (AFC) greater than 24.
Main reasons for not taking part
- More than 2 failed IVF cycles
- Body Mass Index of 35 or more
- Not willing to have embryos biopsied for PGT
- Not planning an embryo transfer within 4 months after the IVM cycle
- Sperm or partner age outside the limits (paternal or donor age under 45, sperm morphology >1%, motility >20%, sperm count >10 million per ml)
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Infertile women diagnosed with PCOS or polycystic ovaries, or infertile women with good ovarian reserve
- Antral follicle count (AFC) greater than 24
- AMH greater than 3.5 ng/ml
- Body Mass Index less than 35
- Accept to have embryos biopsied for PGT
- Intend to perform embryo transfer within 4 months after completing the IVM cycle
- Paternal (or donor) age \<45, ejaculated sperm collection only (partner frozen and donor sperm acceptable), sperm morphology (strict criteria) \>1%, motility \> 20% and sperm count \> 10 million per ml (so samples can be prepared through standard procedure)
Who cannot take part
- More than 2 failed IVF cycles
Where in United States
- Colorado Center for Reproductive MedicineLone Tree, United StatesContact: Rachel Study CoordinatorTaking people
About the trial
What the trial wants to find out
CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication
The group in the trial
- Biphasic IVM TreatmentTreatment being tested
Biphasic IVM of oocytes
Treatment: IVM
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- In Vitro Maturation of Human Eggs
- Plain-language title
- Testing in vitro maturation of eggs in women with fertility concernsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 October 2024